| Lactose (India) Ltd | 131 Cr. | 104 | 231/84.3 | 29.0 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.54 Cr. | 1.85 | 4.29/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,792 Cr. | 441 | 479/192 | 99.2 | 24.3 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 35.8 Cr. | 48.2 | 88.6/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 52.7 Cr. | 36.0 | 36.6/17.0 | 125 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 57.1 Cr. | 75.9 | 119/69.7 | 15.4 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 57,160 Cr. | 2,026 | 2,286/1,275 | 22.7 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 359 Cr. | 14.8 | 19.0/10.8 | 21.5 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 18.0/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 824 Cr. | 1,536 | 1,999/635 | 28.5 | 334 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 94.2 Cr. | 18.8 | 32.0/17.0 | 25.7 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 1,029 Cr. | 350 | 449/219 | 9.19 | 133 | 0.71 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 3.30 Cr. | 15.7 | 39.0/15.2 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 8.31 Cr. | 3.34 | 8.28/2.11 | 4.72 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 486 Cr. | 500 | 517/211 | 73.3 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,919 Cr. | 1,130 | 1,565/944 | 44.5 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 55.2 Cr. | 0.27 | 1.12/0.24 | 3.63 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 44.4 Cr. | 16.9 | 26.3/11.4 | 21.7 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.99 Cr. | 9.90 | 17.0/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 158 Cr. | 442 | 859/429 | 8.93 | 596 | 0.34 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 81.1 Cr. | 81.1 | 92.5/26.1 | 153 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 13,981 Cr. | 1,336 | 2,452/1,315 | 43.5 | 174 | 0.80 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 23.4 Cr. | 51.3 | 88.7/36.1 | 50.9 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 14.0 Cr. | 5.58 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 19.7 Cr. | 132 | 152/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 65.6 Cr. | 120 | 120/9.41 | 45.2 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 31.1 Cr. | 41.2 | 80.0/33.0 | 50.2 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.15 Cr. | 20.5 | 25.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,181 Cr. | 529 | 1,028/512 | 26.0 | 72.4 | 0.23 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 86.8 Cr. | 20.1 | 35.9/18.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 12.1 Cr. | 23.9 | 43.0/17.4 | 52.7 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 89,362 Cr. | 2,165 | 2,998/2,090 | 53.6 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 242 Cr. | 421 | 524/241 | 24.9 | 123 | 1.07 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 53.7 Cr. | 37.4 | 52.2/26.7 | 83.9 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 69,395 Cr. | 1,193 | 1,365/994 | 20.3 | 603 | 0.34 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 152 Cr. | 244 | 303/159 | 145 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 789 Cr. | 78.7 | 117/74.0 | 20.4 | 32.6 | 1.91 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 38.7 Cr. | 29.6 | 46.0/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,349 Cr. | 1,751 | 1,902/919 | 64.1 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.03 Cr. | 0.61 | 1.33/0.51 | 101 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 221 Cr. | 28.9 | 60.0/26.0 | 14.2 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 5.39 Cr. | 9.21 | 21.1/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 125 Cr. | 5.32 | 6.57/2.82 | 291 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 60,437 Cr. | 28,485 | 37,000/25,260 | 40.0 | 1,888 | 1.67 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,747 Cr. | 744 | 972/557 | 28.1 | 226 | 0.67 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 192 Cr. | 67.6 | 100/31.3 | 53.5 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 5,043 Cr. | 1,520 | 1,740/752 | | 103 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 23,126 Cr. | 1,423 | 1,870/1,110 | 421 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 800 Cr. | 230 | 330/154 | 18.6 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 140 Cr. | 16.8 | 29.4/16.8 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,015 Cr. | 760 | 849/270 | 16.0 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,101 Cr. | 440 | 791/430 | 21.3 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,455 Cr. | 1,027 | 1,436/991 | 20.6 | 768 | 0.97 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,30,529 Cr. | 3,848 | 3,882/2,886 | 60.2 | 250 | 0.83 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 919 Cr. | 99.8 | 284/98.0 | | 41.3 | 0.50 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,323 Cr. | 14.1 | 23.5/14.0 | 21.0 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 20,012 Cr. | 523 | 1,328/518 | 58.2 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,733 Cr. | 165 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,12,938 Cr. | 1,721 | 1,900/1,547 | 35.8 | 324 | 0.93 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,506 Cr. | 562 | 734/441 | 391 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,938 Cr. | 313 | 335/175 | 36.2 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,193 Cr. | 317 | 502/265 | 40.0 | 125 | 0.16 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 9,119 Cr. | 209 | 260/111 | 211 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,427 Cr. | 4,098 | 6,718/4,050 | 25.5 | 340 | 2.86 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,809 Cr. | 2,301 | 2,725/1,772 | 34.2 | 335 | 0.86 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,506 Cr. | 5,727 | 6,739/4,904 | 31.0 | 373 | 2.18 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 169 Cr. | 47.9 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,522 Cr. | 4,923 | 5,993/3,701 | 31.9 | 841 | 0.71 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 125 Cr. | 102 | 220/81.0 | 13.0 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,305 Cr. | 376 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,968 Cr. | 782 | 1,998/604 | 75.9 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 19,333 Cr. | 15,069 | 19,748/10,060 | 98.7 | 1,263 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 459 Cr. | 20.5 | 41.4/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 15,883 Cr. | 887 | 1,420/660 | 10.4 | 483 | 0.66 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,247 Cr. | 41.0 | 80.7/38.4 | 29.8 | 21.8 | 0.49 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,173 Cr. | 180 | 307/162 | 23.2 | 59.3 | 0.44 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 45.8 Cr. | 29.0 | 130/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 270 Cr. | 75.7 | 167/72.2 | 132 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 95,939 Cr. | 2,100 | 2,403/1,774 | 22.2 | 430 | 0.58 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 959 Cr. | 479 | 872/464 | 12.0 | 357 | 0.37 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 59,695 Cr. | 1,106 | 1,119/501 | 87.4 | 91.1 | 0.11 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,162 Cr. | 1,120 | 1,235/596 | 23.7 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 148 Cr. | 68.6 | 114/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 732 Cr. | 152 | 219/123 | 41.6 | 104 | 1.97 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 630 Cr. | 360 | 500/265 | 22.8 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 16,860 Cr. | 1,058 | 1,250/802 | 33.9 | 414 | 0.46 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,437 Cr. | 1,815 | 1,918/1,303 | 39.6 | 243 | 0.86 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,284 Cr. | 192 | 302/190 | 29.3 | 38.0 | 1.30 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,055 Cr. | 1,421 | 1,758/1,168 | 36.4 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,405 Cr. | 82.0 | 127/57.5 | 20.7 | 59.7 | 0.96 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 33.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 738 Cr. | 90.5 | 124/67.2 | 24.9 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,115 Cr. | 229 | 350/190 | | 106 | 0.09 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,797 Cr. | 227 | 457/217 | 277 | 96.9 | 0.62 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,363 Cr. | 1,594 | 2,496/1,243 | 31.1 | 397 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,416 Cr. | 341 | 498/285 | 62.9 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 15,025 Cr. | 619 | 627/412 | 29.4 | 164 | 0.24 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 57,160 Cr. | 2,026 | 2,286/1,275 | 22.7 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 41,649 Cr. | 2,456 | 3,516/1,921 | 43.7 | 101 | 1.71 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 28,252 Cr. | 1,715 | 2,131/1,200 | 24.4 | 610 | 1.05 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,816 Cr. | 419 | 528/359 | 30.2 | 149 | 1.19 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 20,476 Cr. | 1,501 | 1,910/1,097 | 49.2 | 227 | 0.49 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,04,641 Cr. | 1,253 | 1,406/1,020 | 18.1 | 432 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,016 Cr. | 256 | 322/178 | 26.9 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,21,270 Cr. | 1,501 | 1,673/1,310 | 22.3 | 408 | 0.87 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,651 Cr. | 1,799 | 2,626/1,551 | 23.2 | 416 | 0.33 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 228 Cr. | 77.6 | 203/68.1 | 16.4 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,714 Cr. | 162 | 191/105 | 15.6 | 107 | 0.31 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 52.8 Cr. | 33.0 | 63.1/32.5 | 18.5 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 51,841 Cr. | 388 | 425/291 | 109 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,560 Cr. | 1,545 | 2,000/1,430 | 34.5 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 116 Cr. | 73.0 | 132/67.2 | 17.1 | 49.2 | 1.64 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 341 Cr. | 148 | 205/67.8 | 32.2 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 21,990 Cr. | 8,778 | 10,691/6,502 | 95.1 | 320 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,930 Cr. | 667 | 843/544 | 34.0 | 118 | 0.69 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 167 Cr. | 78.8 | 137/73.6 | 8.85 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 65,340 Cr. | 5,464 | 5,868/4,492 | 27.8 | 1,116 | 0.82 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 16,425 Cr. | 838 | 1,124/725 | 25.9 | 271 | 1.31 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 420 Cr. | 740 | 1,412/730 | | 690 | 0.68 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 36,693 Cr. | 2,938 | 3,094/2,022 | 37.7 | 345 | 0.95 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,414 Cr. | 304 | 367/258 | 23.2 | 133 | 1.71 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,801 Cr. | 417 | 575/312 | 20.0 | 147 | 0.24 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,126.51 Cr | 1,146.09 | | 53.33 | 202.18 | 0.35% | 16.29% | 15.20% | 6.10 |